Filing Details
- Accession Number:
- 0001144204-15-061079
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-10-27 18:16:18
- Reporting Period:
- 2015-09-28
- Filing Date:
- 2015-10-27
- Accepted Time:
- 2015-10-27 18:16:18
- Original Submission Date:
- 2015-09-28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1430306 | Tonix Pharmaceuticals Holding Corp. | TNXP | Pharmaceutical Preparations (2834) | 261434750 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1610106 | M Gregory Sullivan | C/O Tonix Pharmaceuticals Holding Corp. 509 Madison Avenue, Suite 306 New York NY 10022 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Acquisiton | 2015-09-28 | 4,694 | $5.95 | 15,457 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $5.9491. The range of purchase prices on the transaction date was $5.89 to $6.00 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Billionaire Hedge Funds
